OBJECTIVE: A small randomized controlled trial suggested that vitamin D might increase the production of testosterone in men, which is supported by experimental studies in animals and a cross-sectional study showing positive associations between plasma 25-hydroxyvitamin D [25(OH)D] and testosterone and concordant seasonal variation of both biomarkers. DESIGN AND MEASUREMENTS: We investigated the cross-sectional association of plasma 25(OH)D levels and total and free testosterone measured by immunoassay in 1362 male participants of the Health Professionals Follow-up Study who were selected for a nested case-control study on prostate cancer using multivariate-adjusted linear and restricted cubic spline regression models. RESULTS: 25(OH)D was positively associated with total and free testosterone levels. From the lowest to the highest 25(OH)D quintile, multivariate-adjusted means (95% confidence interval) were 18·5 (17·7; 19·4), 19·4 (18·6; 20·2), 19·6 (18·8; 20·4), 20·1 (19·3; 20·9) and 20·0 (19·1; 20·8; P-trend = 0·003) for total testosterone and 97·7 (93·9; 101·5), 98·2 (94·1; 102·2), 99·2 (95·2; 103·2), 100·7 (96·9; 104·5) and 101·5 (97·6; 105·4; P-trend = 0·03) for free testosterone. The shapes of the dose-response curves indicate that the association between 25(OH)D and total and free testosterone is linear at lower levels of 25(OH)D (below approximately 75-85 nmol/l), reaching a plateau at higher levels. Unlike for 25(OH)D, we did not observe any seasonal variation of testosterone concentrations. CONCLUSION: This study supports previously reported positive associations between vitamin D and testosterone although we did not observe parallel seasonal variation patterns. Possible causality and direction of the vitamin D-testosterone association deserve further scientific investigation.
OBJECTIVE: A small randomized controlled trial suggested that vitamin D might increase the production of testosterone in men, which is supported by experimental studies in animals and a cross-sectional study showing positive associations between plasma 25-hydroxyvitamin D [25(OH)D] and testosterone and concordant seasonal variation of both biomarkers. DESIGN AND MEASUREMENTS: We investigated the cross-sectional association of plasma 25(OH)D levels and total and freetestosterone measured by immunoassay in 1362 male participants of the Health Professionals Follow-up Study who were selected for a nested case-control study on prostate cancer using multivariate-adjusted linear and restricted cubic spline regression models. RESULTS:25(OH)D was positively associated with total and freetestosterone levels. From the lowest to the highest 25(OH)D quintile, multivariate-adjusted means (95% confidence interval) were 18·5 (17·7; 19·4), 19·4 (18·6; 20·2), 19·6 (18·8; 20·4), 20·1 (19·3; 20·9) and 20·0 (19·1; 20·8; P-trend = 0·003) for total testosterone and 97·7 (93·9; 101·5), 98·2 (94·1; 102·2), 99·2 (95·2; 103·2), 100·7 (96·9; 104·5) and 101·5 (97·6; 105·4; P-trend = 0·03) for freetestosterone. The shapes of the dose-response curves indicate that the association between 25(OH)D and total and freetestosterone is linear at lower levels of 25(OH)D (below approximately 75-85 nmol/l), reaching a plateau at higher levels. Unlike for 25(OH)D, we did not observe any seasonal variation of testosterone concentrations. CONCLUSION: This study supports previously reported positive associations between vitamin D and testosterone although we did not observe parallel seasonal variation patterns. Possible causality and direction of the vitamin D-testosterone association deserve further scientific investigation.
Authors: Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi Journal: N Engl J Med Date: 2010-06-16 Impact factor: 91.245
Authors: Martin Blomberg Jensen; John E Nielsen; Anne Jørgensen; Ewa Rajpert-De Meyts; David Møbjerg Kristensen; Niels Jørgensen; Niels E Skakkebaek; Anders Juul; Henrik Leffers Journal: Hum Reprod Date: 2010-02-18 Impact factor: 6.918
Authors: Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2010-06 Impact factor: 5.958
Authors: Martin Blomberg Jensen; Poul J Bjerrum; Torben E Jessen; John E Nielsen; Ulla N Joensen; Inge A Olesen; Jørgen H Petersen; Anders Juul; Steen Dissing; Niels Jørgensen Journal: Hum Reprod Date: 2011-03-22 Impact factor: 6.918
Authors: S Pilz; S Frisch; H Koertke; J Kuhn; J Dreier; B Obermayer-Pietsch; E Wehr; A Zittermann Journal: Horm Metab Res Date: 2010-12-10 Impact factor: 2.936
Authors: Di Zhao; Pamela Ouyang; Ian H de Boer; Pamela L Lutsey; Youssef M K Farag; Eliseo Guallar; David S Siscovick; Wendy S Post; Rita R Kalyani; Kevin L Billups; Erin D Michos Journal: Maturitas Date: 2016-11-29 Impact factor: 4.342
Authors: C Foresta; R Selice; L De Toni; A Di Mambro; U Carraro; M Plebani; A Garolla Journal: J Endocrinol Invest Date: 2012-10-09 Impact factor: 4.256
Authors: Alison M Mondul; Irene M Shui; Kai Yu; Ruth C Travis; Victoria L Stevens; Daniele Campa; Frederick R Schumacher; Regina G Ziegler; H Bas Bueno-de-Mesquita; Sonja Berndt; E D Crawford; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Christopher A Haiman; Brian E Henderson; David J Hunter; Mattias Johansson; Timothy J Key; Loïc Le Marchand; Sara Lindström; Marjorie L McCullough; Carmen Navarro; Kim Overvad; Domenico Palli; Mark Purdue; Meir J Stampfer; Stephanie J Weinstein; Walter C Willett; Meredith Yeager; Stephen J Chanock; Dimitrios Trichopoulos; Laurence N Kolonel; Peter Kraft; Demetrius Albanes Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-02-01 Impact factor: 4.254
Authors: Gabriella M Anic; Demetrius Albanes; Sabine Rohrmann; Norma Kanarek; William G Nelson; Gary Bradwin; Nader Rifai; Katherine A McGlynn; Elizabeth A Platz; Alison M Mondul Journal: Clin Endocrinol (Oxf) Date: 2016-04-06 Impact factor: 3.478